Restoration of miR-23a expression by chidamide sensitizes CML cells to imatinib treatment with concomitant downregulation of CRYAB-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Restoration of miR-23a expression by chidamide sensitizes CML cells to imatinib treatment with concomitant downregulation of CRYAB

Published:2022-03-25 Issue:4 Volume:13 Page:8881-8892
ISSN:2165-5979
Container-title:Bioengineered
language:en
Short-container-title:Bioengineered

Author:

Zhu Xunxun¹²^ORCID,Zhang Jingru¹,Sun Yanping¹,Wang Yan¹³,Liu Qian¹,Li Peng¹,Yu Shuang¹,Liu Na¹,Ye Jingjing¹,Ma Daoxin¹,Ji Chunyan¹

Affiliation:

1. Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, shandong, China

2. Department of Hematology, Tengzhou Central People’s Hospital, Tengzhou, Shandong, China

3. Department of Hematology, Taian Central Hospital, Taian, Shandong, China

Publisher

Informa UK Limited

Subject

Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21655979.2022.2056322

Reference34 articles.

1. Prognosis for patients with CML and >10% BCR-ABL1 after 3 months of imatinib depends on the rate of BCR-ABL1 decline

2. Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia

3. Imatinib for Chronic Myeloid Leukemia: The Impact of Its Effectiveness and Long-term Side Effects

4. Chronic Myeloid Leukemia: Overview of New Agents and Comparative Analysis

5. Management of imatinib-resistant patients with chronic myeloid leukemia

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in hematopoietic cell kinase in cancer progression: Mechanisms and inhibitors;Biomedicine & Pharmacotherapy;2024-07

2. Non-coding RNAs in leukemia drug resistance: new perspectives on molecular mechanisms and signaling pathways;Annals of Hematology;2023-08-01

3. Synthesis and Crystal Structure Analysis of Histone Deacetylase Inhibitor Chidamide;Pharmaceutical Fronts;2023-05-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3